COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2021
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $33,253,682.42 |
| Submission deadline | Deadline not published |
| Published | Sep 16, 2019 |
| Buyer | National Institutes of Health |
| Country | United States · MD |
| CPV code | NAICS 541715 (RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND L) · PSC AN12 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $33,253,682.42
- Submission deadline
- Deadline not published
- Published
- Sep 16, 2019
- Country
- United States
- CPV code
- NAICS 541715 (RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND L) · PSC AN12
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| UNIVERSITY OF MARYLAND, BALTIMORE | US-UEI: Z9CRZKD42ZT1 | United States | $33,253,682.42 | Sep 16, 2019 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE INITIAL AWARD: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2021
Awarding Agency: Department of Health and Human Services — National Institutes of Health.
NAICS 541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY).
PSC AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Period of Performance: 2019-09-16 to 2030-09-15.